NCT02101541View on ClinicalTrials.gov

FIRM as a Stand-alone Procedure in the Treatment of Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

June 30, 2016

Conditions
Atrial Fibrillation
Interventions
PROCEDURE

FIRM ablation

Radiofrequency catheter ablation of atrial fibrillation driving sources detected by sequential bi-atrial panoramic contact mapping.

Trial Locations (1)

Unknown

Dept. of Cardiology, Rikshospitalet - Oslo University Hospital, Oslo

All Listed Sponsors
lead

Oslo University Hospital

OTHER

NCT02101541 - FIRM as a Stand-alone Procedure in the Treatment of Atrial Fibrillation | Biotech Hunter | Biotech Hunter